4//SEC Filing
Hemmi Gregory 4
Accession 0001209191-13-002940
CIK 0000949699other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:30 PM ET
Size
16.0 KB
Accession
0001209191-13-002940
Insider Transaction Report
Form 4
Hemmi Gregory
VP Chemical Operations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2013-01-11−3,047→ 71,953 totalExercise: $2.76From: 2007-03-13Exp: 2017-03-13→ Common Stock (3,047 underlying) - Exercise/Conversion
Common Stock
2013-01-11$4.16/sh+1,415$5,886→ 24,945 total - Sale
Common Stock
2013-01-11$67.11/sh−5,000$335,550→ 22,992 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-01-11−538→ 7,462 totalExercise: $7.76From: 2005-06-03Exp: 2015-06-03→ Common Stock (538 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2013-01-11−1,415→ 83,585 totalExercise: $4.16From: 2006-05-23Exp: 2016-05-23→ Commonn Stock (1,415 underlying) - Exercise/Conversion
Common Stock
2013-01-11$7.76/sh+538$4,175→ 23,530 total - Exercise/Conversion
Common Stock
2013-01-11$2.76/sh+3,047$8,410→ 27,992 total
Footnotes (1)
- [F1]Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests in forty-eight (48) equal and successive monthly installments.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeother
Related Parties
1- filerCIK 0001507649
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 7:30 PM ET
- Size
- 16.0 KB